Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18763966 | Aligning Image Data of a Patient with Actual Views of the Patient Using an Optical Code Affixed to the Patient | July 2024 | February 2025 | Allow | 8 | 0 | 0 | Yes | No |
| 18635048 | CLINICAL RISK PREDICTION SYSTEM ORIENTED TO DATA DISTRIBUTION DRIFT DETECTION AND SELF-ADAPTATION | April 2024 | September 2025 | Abandon | 17 | 2 | 0 | No | No |
| 18681176 | METHOD AND SERVER FOR GENERATING, ON BASIS OF LANGUAGE MODEL, QUESTIONS OF PERSONALITY APTITUDE TEST BY USING QUESTION AND ANSWER NETWORK | February 2024 | December 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18426250 | ADVISING DIABETES MEDICATIONS | January 2024 | October 2024 | Allow | 8 | 0 | 0 | Yes | No |
| 18453759 | SYSTEM AND METHOD FOR MEASURING THE TREATMENT EFFECT OF A DRUG | August 2023 | November 2025 | Abandon | 27 | 2 | 0 | Yes | No |
| 18230973 | COMPUTER GRAPHICAL INTERFACE PROCESSING WITH REMOTE COMPUTING DEVICES | August 2023 | March 2026 | Abandon | 31 | 1 | 0 | No | No |
| 18364563 | MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM | August 2023 | December 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18221867 | SYSTEM FOR MEDICAL TREATMENT RECOMMENDATION AND PREDICTIVE MODEL THEREOF | July 2023 | November 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18039609 | REHABILITATION APPROACH PROPOSAL APPARATUS, REHABILITATION APPROACH PROPOSAL METHOD, AND NON-TRANSITORY COMPUTER-READABLE MEDIUM | May 2023 | September 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18140235 | MONITORING PATIENT DATA | April 2023 | January 2026 | Abandon | 33 | 1 | 0 | No | No |
| 18032487 | SYSTEM, ELECTRONIC DEVICE, METHOD, AND PROGRAM FOR ADJUSTING INTAKE OF DRUG | April 2023 | September 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18181733 | SYSTEMS AND METHODS FOR PROVENANCE AND DATA INTEGRITY MONITORING | March 2023 | December 2025 | Abandon | 33 | 2 | 0 | Yes | No |
| 18116980 | AVAILABILITY INDEX FOR CONNECTING WITH A USER VIA A NETWORK DEVICE | March 2023 | December 2025 | Abandon | 34 | 2 | 0 | No | No |
| 18091086 | APPARATUS FOR PREVENTING DECLINE OF LONGEVITY | December 2022 | September 2024 | Abandon | 21 | 7 | 0 | Yes | No |
| 17684872 | METHOD OF MAPPING PATIENT-HEALTHCARE ENCOUNTERS AND TRAINING MACHINE LEARNING MODELS | March 2022 | November 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17673095 | SYSTEM FOR REALIZING REMOTE MONITORING OF MOVEMENT HEALTH OF PET | February 2022 | April 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17671992 | ELECTRONIC DEVICE AND OPERATION METHOD OF ELECTRONIC DEVICE | February 2022 | September 2025 | Abandon | 43 | 3 | 0 | No | No |
| 17672318 | INSTRUCTION DOCUMENT CREATING SYSTEM | February 2022 | January 2026 | Abandon | 47 | 4 | 0 | No | Yes |
| 17666787 | Medical Intelligence System and Method | February 2022 | April 2025 | Abandon | 38 | 2 | 0 | No | No |
| 17591083 | DIAGNOSIS ASSISTANCE APPARATUS AND DIAGNOSIS ASSISTANCE SYSTEM | February 2022 | February 2026 | Abandon | 48 | 4 | 0 | Yes | No |
| 17614265 | A METHOD OF TREATMENT OR PROPHYLAXIS | November 2021 | October 2025 | Allow | 46 | 2 | 0 | No | Yes |
| 17514091 | INFORMATION PROCESSING APPARATUS AND METHOD | October 2021 | January 2025 | Abandon | 39 | 2 | 0 | No | No |
| 17428619 | METHOD FOR DATA PROCESSING TO DERIVE NEW DRUG CANDIDATE SUBSTANCE | August 2021 | September 2025 | Abandon | 49 | 2 | 0 | Yes | Yes |
| 17417406 | AUTOMATED DETECTION OF LUNG CONDITIONS FOR MONITORING THORACIC PATIENTS UNDERTGOING EXTERNAL BEAM RADIATION THERAPY | June 2021 | November 2025 | Allow | 53 | 4 | 0 | Yes | No |
| 17350533 | PREDICTIVE METABOLIC INTERVENTION | June 2021 | September 2025 | Abandon | 51 | 5 | 0 | Yes | No |
| 17342517 | METHOD FOR DETERMINING TRAINING STATUS SELECTED FROM A SET OF TRAINING STATUS ALTERNATIVES | June 2021 | December 2025 | Abandon | 54 | 2 | 0 | No | No |
| 17224110 | SYSTEM AND METHOD FOR AUTOMATED HEALTH AND FITNESS ADVISEMENT | April 2021 | April 2025 | Abandon | 48 | 3 | 0 | Yes | No |
| 17217008 | SYSTEMS AND METHODS OF INTEGRATING MEDICAL DEVICE CASE FILES WITH CORRESPONDING PATIENT CARE RECORDS | March 2021 | February 2026 | Allow | 59 | 6 | 0 | Yes | No |
| 17189820 | Techniques For Delivering Real-Time Point Of Care Messaging To Health Care Providers | March 2021 | January 2026 | Abandon | 58 | 4 | 0 | Yes | Yes |
| 17132189 | SYSTEMS AND METHODS FOR NETWORK MONITORING IN REMOTE THERAPY SYSTEMS | December 2020 | November 2024 | Abandon | 46 | 4 | 0 | No | No |
| 17015092 | MEDICAL EXAMINATION MANAGEMENT DEVICE, MEDICAL EXAMINATION MANAGEMENT METHOD, AND PROGRAM | September 2020 | June 2025 | Abandon | 58 | 4 | 0 | No | No |
| 16772534 | DIGITAL HEALTH PROXY SYSTEM AND DEVICE | June 2020 | June 2025 | Abandon | 60 | 6 | 0 | Yes | No |
| 16827218 | ENHANCED PRESCRIPTION MANAGEMENT SYSTEM | March 2020 | March 2025 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16300279 | METHOD, COMMUNICATION SYSTEM AND COMPUTER PROGRAM FOR PROVIDING INFORMATION INDICATIVE OF CONCENTRATION OF ALLERGENS IN THE ENVIRONMENT | November 2018 | June 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 16177314 | ENHANCED PRESCRIPTION MANAGEMENT SYSTEM | October 2018 | November 2025 | Abandon | 60 | 8 | 0 | Yes | Yes |
| 15951463 | EXPEDITED ADMISSIONS AND MEDICATION DELIVERY | April 2018 | March 2025 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 15784144 | SECURE DATABASE SYSTEMS AND METHODS FOR DELIVERING HEALTH CARE TREATMENT | October 2017 | December 2024 | Abandon | 60 | 8 | 0 | No | No |
| 14748815 | Systems, Methods and Computer Program Products for Reducing the Risk of Persons Housed Within a Facility Being Sexual Predators or Victims | June 2015 | September 2019 | Allow | 51 | 2 | 0 | Yes | Yes |
| 14538802 | SYSTEMS AND METHODS FOR A MEDICAL CODER MARKETPLACE | November 2014 | May 2025 | Abandon | 60 | 13 | 0 | Yes | No |
| 12365151 | NAVIGATION SYSTEM WITH PATH PREDICTION AND METHOD OF OPERATION THEREOF | February 2009 | September 2015 | Allow | 60 | 2 | 0 | No | Yes |
| 12347371 | METHOD AND APPARATUS FOR PROVIDING MAPPING DATA | December 2008 | September 2015 | Allow | 60 | 6 | 0 | Yes | No |
| 11936018 | METHODS FOR DEVELOPING AND CONDUCTING A NUTRITIONAL TREATMENT PROGRAM | November 2007 | April 2010 | Allow | 30 | 1 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WINSTON III, EDWARD B.
With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 37.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner WINSTON III, EDWARD B works in Art Unit 3683 and has examined 22 patent applications in our dataset. With an allowance rate of 31.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 58 months.
Examiner WINSTON III, EDWARD B's allowance rate of 31.8% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by WINSTON III, EDWARD B receive 4.64 office actions before reaching final disposition. This places the examiner in the 99% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by WINSTON III, EDWARD B is 58 months. This places the examiner in the 1% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +4.8% benefit to allowance rate for applications examined by WINSTON III, EDWARD B. This interview benefit is in the 29% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 4.4% of applications are subsequently allowed. This success rate is in the 2% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 12.5% of cases where such amendments are filed. This entry rate is in the 13% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 42.9% of appeals filed. This is in the 9% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 4.5% of allowed cases (in the 85% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.